In one of the biggest breakthroughs in schizophrenia research in recent times, Professor Cynthia Shannon Weickert at Neuroscience Research Australia (NeuRA) has identified immune cells in greater amounts in the brains of some people with schizophrenia. The study published today in Molecular Psychiatry has the potential to transform global schizophrenia research and open new avenues for developing targeted immune cell therapies.
One in every 100 Australians lives with schizophrenia. No single cause of schizophrenia has been identified, and this has prevented the development of a cure. The current treatments for schizophrenia are designed to suppress symptoms rather than target underlying causes of the disorder. These drugs only partially relieve symptoms and can produce unwanted side effects.
To recognise the significance of this discovery Professor Shannon Weickert says you first need to understand most scientists have had a long held belief that immune cells were independent from the brain pathology in psychotic illnesses.
“In our study, we challenged this assumption that immune cells were independent of the brain in psychiatric illness and made an exciting discovery. We identified immune cells as a new player in the brain pathology of schizophrenia,” said Professor Shannon Weickert.
Current schizophrenia research has focused on the status of three brain cells: the neurons; the glial cells, which support the neurons; and the endothelial cells, which coat the blood vessels. Employing new molecular techniques allowed Professor Shannon Weickert and her team to identify the presence of a fourth cell, the macrophage, a type of immune cell in the brain tissue of people with schizophrenia who show high levels of inflammation.
Professor Shannon Weickert said immune cells have previously been ignored as they had long been viewed simply as travelers just thought to be passing by, undertaking surveillance work. They have never been a suspect until now.
“To find immune cells along the blood brain barrier in increased amounts in people with schizophrenia is an exciting discovery. It suggests immune cells themselves may be producing these inflammatory signals in the brains of people living with schizophrenia,” said Professor Shannon Weickert.
“We have observed in people with schizophrenia, the glial cells, one of the local residents, become inflamed and produce distress signals which change the status of the endothelial cells.
“We think this may cause the endothelial cells to extend sticky tentacles, so when the immune cells travel by some are captured. These cells may transmigrate across the blood brain barrier entering the brain in greater amounts in some people with schizophrenia compared to people without the disorder.”
This discovery shows that specific immune cells are in the brains of some people with schizophrenia in close enough proximity to the neurons to do damage.
Professor Peter Schofield, CEO of NeuRA said this innovative new research has the ability to alter the way in which we may be able to diagnose and treat schizophrenia.
“This breakthrough demonstrates the value of the NSW Government’s support for Professor Shannon Weickert as NSW Chair of Schizophrenia Research, which has delivered new insights that the community seeks,” said Professor Schofield.
Professor Shannon Weickert is encouraging a cross-collaborative approach between neuroscientists and immunologists globally, to work together to develop treatments targeting this abnormal immune pathology of schizophrenia.
“This opens whole new avenues for therapy, because it suggests that the pathology of schizophrenia could be within the immune cells and the immune cells could be contributing to the symptoms of schizophrenia,” said Professor Shannon Weickert.
Professor Shannon Weickert is uniquely motivated in her work, with her twin-brother being diagnosed with schizophrenia when he was 17 years old.
Learn more: Schizophrenia breakthrough
The Latest on: Schizophrenia
via Google News
The Latest on: Schizophrenia
- Bimodal distribution of tone-matching deficits indicates discrete pathophysiological entities within the syndrome of schizophreniaon September 6, 2019 at 6:57 am
In 1911, Bleuler famously described the syndrome of dementia pracecox as including a “group of schizophrenias” (SZ), reflecting the strong heterogeneity of presentation across individuals 1.
- Saladax Develops First-Ever Rapid Test for an Antipsychotic Drug Using a Single Drop of Blood to Aid Psychiatrists in the Treatment of Schizophreniaon September 5, 2019 at 6:31 am
MyCare Insite Clozapine Test provides results in 6 minutes using a drop of blood from a finger stick enabling clinicians to develop informed, individualized care plans at the point of care (POC). This ...
- Neurobiological pathophysiology of schizophrenia differs based on genderon September 4, 2019 at 12:39 am
The neurobiological pathophysiology of schizophrenia differs significantly between males and females, according to a new study. The findings suggest a possible need for more sex-specific treatments ...
- ONLY ON ABC7NEWS.COM: Mother of man found dead after ramming through Oakland Airport gate says son struggled with drugs, schizophreniaon September 3, 2019 at 5:51 pm
APTOS, Calif. (KGO) -- The mother of a man who rammed through a gate at Oakland International Airport is speaking exclusively with ABC7 News. According to the Alameda County Sheriff's Department ...
- The neurobiological mechanisms behind schizophrenia may depend on genderon September 3, 2019 at 7:37 am
The neurobiological pathophysiology of schizophrenia differs significantly between males and females, according to a new study. The findings suggest a possible need for more sex-specific ...
- Potentially repurposable drugs for schizophrenia identified from its interactomeon September 3, 2019 at 2:09 am
We previously presented the protein-protein interaction network of schizophrenia associated genes, and from it, the drug-protein interactome which showed the drugs that target any of the proteins in ...
- Why is Clozapine Underused in Schizophrenia?on August 31, 2019 at 3:43 am
Schizophrenia can be a difficult-to-manage disease with roughly one-third of all patients developing treatment-resistance (Essali, Al-Haj Hassan, Li, & Rathbone, 2009). While various definitions of ...
- Family searching for relative with schizophrenia after he was released from BCSO custodyon August 30, 2019 at 8:33 pm
SAN ANTONIO — A San Antonio family says they are looking for one of their own after he was taken into custody by Bexar County deputies who mistook him for a cousin who has outstanding warrants before ...
- 10 Facts You Should Know About Schizophreniaon August 29, 2019 at 11:14 am
Of all the misunderstood mental illnesses, schizophrenia gets an especially bad rap. The condition is characterized by disordered thoughts, unusual speech and behavior, and an inaccurate view of ...
via Bing News